المؤلفون: Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Georgy M. Ignatyev, Ilya V. Gordeychuk, Viktor P. Volok, Yulia V. Rogova, Anna A. Shishova, Anastasia A. Kovpak, Yury Yu. Ivin, Liliya P. Antonova, Kirill M. Mefyod, Lyubov S. Prokosheva, Anna S. Sibirkina, Yuliya Yu. Tarasova, Ekaterina O. Bayurova, Olga S. Gancharova, Victoria V. Illarionova, Grigory S. Glukhov, Olga S. Sokolova, Konstantin V. Shaitan, Anastasia M. Moysenovich, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Larissa V. Gmyl, Elena G. Ipatova, Mikhail P. Kirpichnikov, Alexey M. Egorov, Aleksandra A. Siniugina, Aydar A. Ishmukhametov

المصدر: Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1790-1806 (2021)

مصطلحات موضوعية: Vaccine, SARS-CoV-2, COVID-19, neutralizing antibodies, safety, immunogenicity, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2222-1751

URL الوصول: https://doaj.org/article/25dd68ffe74e41b1a33bb195f5965272

المؤلفون: Liubov I. Kozlovskaya (11413365), Anastasia N. Piniaeva (11413368), Georgy M. Ignatyev (11413371), Ilya V. Gordeychuk (2826434), Viktor P. Volok (11413374), Yulia V. Rogova (400814), Anna A. Shishova (11413377), Anastasia A. Kovpak (11413380), Yury Yu. Ivin (11413383), Liliya P. Antonova (11413386), Kirill M. Mefyod (11413389), Lyubov S. Prokosheva (11413392), Anna S. Sibirkina (11413395), Yuliya Yu. Tarasova (11413398), Ekaterina O. Bayurova (11413401), Olga S. Gancharova (6178112), Victoria V. Illarionova (11413404), Grigory S. Glukhov (11413407), Olga S. Sokolova (4390033), Konstantin V. Shaitan (597724), Anastasia M. Moysenovich (6039092), Stanislav A. Gulyaev (11413410), Tatiana V. Gulyaeva (11413413), Andrey V. Moroz (11413416), Larissa V. Gmyl (11413419), Elena G. Ipatova (11413422), Mikhail P. Kirpichnikov (472252), Alexey M. Egorov (11413425), Aleksandra A. Siniugina (11413428), Aydar A. Ishmukhametov (9592899)

مصطلحات موضوعية: Medicine, Genetics, Neuroscience, Immunology, Cancer, Infectious Diseases, Vaccine, SARS-CoV-2, COVID-19, neutralizing antibodies, safety, immunogenicity, inactivated vaccine, preclinical study

Relation: https://figshare.com/articles/journal_contribution/Long-term_humoral_immunogenicity_safety_and_protective_efficacy_of_inactivated_vaccine_against_COVID-19_CoviVac_in_preclinical_studies/16595382

الاتاحة: https://doi.org/10.6084/m9.figshare.16595382.v1